Selumetinib Sulfate

US Brand Name(s): Koselugo

Use in Cancer Treatment

Selumetinib sulfate is to treat the following conditions:

Children with neurofibromatosis type 1 (NF1) have plexiform neurofibromas that are producing symptoms and cannot be treated surgically.

Selumetinib sulfate is also under research for use in the treatment of various cancers.

Detailed scientific definition – Definition from the NCI Drug Dictionary 

Selumetinib Sulfate – MedlinePlus Information

A summary of key facts regarding this medication in layman’s terms, which may contain the following:

  • Cautions about this medicine
  • What is the use and how?
  • Whom should you consult before taking it?
  • What you should know about it before using it?
  • Other drugs that might interact with it
  • Possible negative effects

Drugs are frequently under research to see whether they can assist treat or prevent conditions other than those already prevalent. This patient information leaflet covers uses which have been under authorization. Much of the material, though, might also apply to authorized uses that are under research.